CD164 antibody

Catalogue No.:FNab01433Reactivity:Human
Host:RabbitTested Application:ELISA, IHC, WB, FC
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
CD164 antibody
Catalogue No.
FNab01433
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
CD164 molecule, sialomucin
UniProt ID
Q04900
Observed MW
82 kDa
Application
Tested Applications
ELISA, IHC, WB, FC
Recommended dilution
WB: 1:500-1:2000; IHC: 1:20-1:200
Validated Images
K-562 cells were subjected to SDS PAGE followed by western blot with FNab01433(CD164 antibody) at dilution of 1:300
Immunohistochemistry of paraffin-embedded human pancreas cancer using FNab01433(CD164 antibody) at dilution of 1:50
Background
Sialomucin that may play a key role in hematopoiesis by facilitating the adhesion of CD34(+) cells to the stroma and by negatively regulating CD34(+)CD38(lo/-) cell proliferation. Modulates the migration of umbilical cord blood CD133+ cells and this is mediated through the CXCL12/CXCR4 axis. May play an important role in prostate cancer metastasis and the infiltration of bone marrow by cancer cells. Promotes myogenesis by enhancing CXCR4-dependent cell motility. Positively regulates myoblast migration and promotes myoblast fusion into myotubes(By similarity).